Ketogenic diet in Dravet Syndrome: Tolerability and main benefits in children
DOI:
https://doi.org/10.33448/rsd-v13i10.47075Keywords:
Myoclonics epilepsies, Ketogenic diet, Children.Abstract
Dravet syndrome is a severe epileptic encephalopathy that manifests in early childhood and is characterized by hemiclonic or tonic-clonic seizures. One of the non-pharmacological treatment options for this condition is the ketogenic diet, which aims to induce ketosis in the body. This diet is widely recognized as a complementary therapy in the management of patients with epilepsy that is resistant to conventional medications. The present study aimed to evaluate the therapeutic role of the ketogenic diet in patients with Dravet syndrome, focusing on its efficacy as an adjunct therapy, diet tolerability, and the main reported adverse effects. For this, a bibliographic search was conducted in the PubMed database through a systematic literature review, analyzing publications from 2014 to 2024 in Portuguese and English. Based on the analyzed data, the use of the ketogenic diet proved to be a promising approach for the treatment of children with Dravet syndrome, demonstrating efficacy in reducing seizure frequency, with adverse effects considered acceptable and good tolerability.
Downloads
References
Aakash, M, Gautam, K, & Gulati, S. (2024). Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_49_24
Anwar, A., Saleem, S., Patel, U. K., Arumaithurai, K., & Malik, P. (2019). Dravet Syndrome: An Overview. Cureus, 11(6). https://doi.org/10.7759/cureus.5006
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022). The Role of Ketogenic Diet in the Treatment of Neurological Diseases. Nutrients, 14(23), 5003. https://doi.org/10.3390/nu14235003
Dressler, A., Trimmel-Schwahofer, P., Reithofer, E., Mühlebner, A., Gröppel, G., Reiter-Fink, E., Benninger, F., Grassl, R., & Feucht, M. (2015). Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen. Epilepsy research, 109, 81–89. https://doi.org/10.1016/j.eplepsyres.2014.10.014
E. Wirrell C. (2016). Tratamento da Síndrome de Dravet. A revista canadense de ciências neurológicas. Le journal canadien des sciences neurologiques, 43 Suppl 3, S13–S18. https://doi.org/10.1017/cjn.2016.24
Kim, S. H., Kang, H. C., Lee, E. J., Lee, J. S., & Kim, H. D. (2017). Low glycemic index treatment in patients with drug-resistant epilepsy. Brain & development, 39(8), 687–692. https://doi.org/10.1016/j.braindev.2017.03.027
Knupp, K. G., Wirrel, E. C. (2018) Treatment strategies for Dravet Syndrome. CNS Drugs, 32 (4), 335-350. https://doi.org/10.1007/s40263-018-0511-y
Kortas, A., Schiller, K., Unterholzner, G., & Rauchenzauner, M. (2020). Accuracy of Flash Glucose Monitoring in a Patient with Dravet Syndrome on a Ketogenic Diet. Neuropediatrics, 51(1), 45–48. https://doi.org/10.1055/s-0039-1697621
Liu, F., Peng, J., Zhu, C., Xiao, H., He, F., Yin, F., & Chen, C. (2019). Efficacy of the ketogenic diet in Chinese children with Dravet syndrome: A focus on neuropsychological development. Epilepsy & behavior : E&B, 92, 98–102. https://doi.org/10.1016/j.yebeh.2018.12.016
Mahesan, A., Kamila, G., & Gulati, S. (2024). Advancements in Dravet syndrome therapeutics: A comprehensive look at present and future treatment horizons: A focused review. Annals of Indian Academy of Neurology, 27(4), 352-357. https://doi.org/10.4103/aian.aian_49_24
McGaugh, E., & Barthel, B. (2022). A Review of Ketogenic Diet and Lifestyle. Missouri medicine, 119(1), 84–88. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312449/
Miller, I. O., & Sotero de Menezes, M. A. (2007) [Updated 2022]. SCN1A Seizure Disorders, GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1318/
Pasca, L., De Giorgis, V., Macasaet, J. A., Trentani, C., Tagliabue, A., & Veggiotti, P. (2016). The changing face of dietary therapy for epilepsy. European journal of pediatrics, 175(10), 1267–1276. https://doi.org/10.1007/s00431-016-2765-z
Sampaio, L. P. de B. (2016). Ketogenic diet for epilepsy treatment. Arquivos de Neuro-Psiquiatria, 74(10), 842–848. https://doi.org/10.1590/0004-282x20160116
Scheffer, I. E., & Nabbout, R. (2019). SCN1A‐related phenotypes: Epilepsy and beyond. Epilepsia, 60(S3). https://doi.org/10.1111/epi.16386
Tian, X., Chen, J., Zhang, J., Yang, X., Ji, T., Zhang, Y., Wu, Y., Fang, F., Wu, X., & Zhang, Y. (2019). The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome. Frontiers in neurology, 10, 625. https://doi.org/10.3389/fneur.2019.00625
Wang, Y. Q., Fang, Z. X., Zhang, Y. W., Xie, L. L., e Jiang, L. (2020). Eficácia da dieta cetogênica em pacientes com síndrome de Dravet: Uma meta-análise. Seizure, 81, 36–42. https://doi.org/10.1016/j.seizure.2020.07.011
Wells, J., Swaminathan, A., Paseka, J., & Hanson, C. (2020). Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy—A Review. Nutrients, 12(6), 1809. https://doi.org/10.3390/nu12061809
Wilmshurst, J. M., Burman, R., Gaillard, W. D., & Cross, J. H. (2015). Treatment of infants with epilepsy: Common practices around the world. Epilepsia, 56(7), 1033–1046. https://doi.org/10.1111/epi.13003
Wirrell, E. C. (2016). Treatment of Dravet Syndrome. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 43(S3), S13–S18. https://doi.org/10.1017/cjn.2016.249
Wu, Q., Wang, H., Fan, Y. Y., Zhang, J. M., Liu, X. Y., Fang, X. Y., Yang, F. H., Cao, Q. J., & Qi, Y. (2018). Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective study. Brain and behavior, 8(5), e00973. https://doi.org/10.1002/brb3.973
Yan, N., Xin-Hua, W., Lin-Mei, Z., Yi-Ming, C., Wen-Hui, L., Yuan-Feng, Z., & Shui-Zhen, Z. (2018). Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome. Seizure, 60, 144–148. https://doi.org/10.1016/j.seizure.2018.06.023
Yu, M., Li, H., Sun, D., Li, D., Zhong, J., Gu, Q., Huang, S., Luo, R., Zhu, D., Yuan, B., Li, B., Xiao, N., Chen, Y., Zhang, Y., Wei, J., Jiang, Y., Liao, J., Qin, J., & China Association Against Epilepsy Ketogenic Diet Group (2023). The ketogenic diet for Dravet syndrome: A multicenter retrospective study. Nutrition (Burbank, Los Angeles County, Calif.), 110, 111976. https://doi.org/10.1016/j.nut.2023.111976
Zimeng, H., Li, Y., Zhao, X., Li, B. (2022). Dravet syndrome: Advances in etiology, clinical presentation, and treatment. Epilepsy Research, 108, 107041. https://doi.org/10.1016/j.eplepsyres.2022.107041
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Bruna Mafra de Mendonça Melo; Flávia Castro Pinto do Rêgo; Laura Júlia Siqueira Limongi; Letícia Magalhães Pedrosa Capitol; Luciana Jordão Brito; Maria Alice de Oliveira Martins; Wagner Gonçalves Horta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
